Loading...
XSHG600587
Market cap1.32bUSD
Jan 15, Last price  
15.95CNY
1D
2.03%
1Q
-10.12%
Jan 2017
-35.96%
Name

Shinva Medical Instrument Co Ltd

Chart & Performance

D1W1MN
XSHG:600587 chart
P/E
14.63
P/S
0.96
EPS
1.09
Div Yield, %
1.09%
Shrs. gr., 5y
9.38%
Rev. gr., 5y
-0.53%
Revenues
10.01b
+7.87%
299,424,076415,249,469483,164,962528,908,872654,964,324885,836,6161,342,233,4082,106,132,0623,035,561,2254,193,764,3176,283,466,6697,554,444,2518,364,495,5309,983,246,17210,283,639,0288,766,761,0759,150,960,4109,482,198,7519,281,768,65710,011,868,423
Net income
654m
+30.78%
015,104,97020,870,10922,433,86529,868,33841,286,79060,352,282107,257,530163,311,032231,680,197326,441,336280,833,88134,636,29065,528,72222,784,139861,314,742234,138,976556,493,783500,072,195653,997,275
CFO
1.03b
+165.46%
16,040,885058,141,917049,285,184106,291,491124,164,572010,867,02522,355,70052,058,790110,434,996188,745,622947,089,785653,215,493630,910,0801,098,102,3941,402,538,527388,048,5661,030,114,479
Dividend
Jun 06, 20240.65 CNY/sh

Profile

Shinva Medical Instrument Co., Ltd. provides medical instruments and equipment in the People's Republic of China. It offers CSSD integrated solutions, pharmaceutical equipment integrated solutions, radiotherapy integrated solutions, digital operating room integrated solutions, dental integrated solutions, medical environmental protection integrated solutions, experiment animal safeguard integrated solutions, in vitro diagnostic reagents and instruments, and biomedical materials and supplies. The company also provides pharmaceutical machinery and air purifiers. Shinva Medical Instrument Co., Ltd. was founded in 1943 and is headquartered in Zibo, the People's Republic of China.
URL
http://www.shinva.net
IPO date
Sep 27, 2002
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
10,011,868
7.87%
9,281,769
-2.11%
Cost of revenue
8,295,856
8,265,173
Unusual Expense (Income)
NOPBT
1,716,012
1,016,596
NOPBT Margin
17.14%
10.95%
Operating Taxes
62,078
46,887
Tax Rate
3.62%
4.61%
NOPAT
1,653,935
969,709
Net income
653,997
30.78%
500,072
-10.14%
Dividends
(103,802)
(61,796)
Dividend yield
0.68%
0.71%
Proceeds from repurchase of equity
(9,441)
BB yield
0.06%
Debt
Debt current
851,947
1,067,016
Long-term debt
212,450
153,559
Deferred revenue
61,668
52,624
Other long-term liabilities
82,143
7,155
Net debt
(3,911,133)
(2,180,564)
Cash flow
Cash from operating activities
1,030,114
388,049
CAPEX
(535,770)
Cash from investing activities
(519,899)
Cash from financing activities
1,065,791
27,810
FCF
1,166,981
840,154
Balance
Cash
3,288,393
1,789,354
Long term investments
1,687,137
1,611,785
Excess cash
4,474,936
2,937,051
Stockholders' equity
4,384,130
4,185,174
Invested Capital
4,444,919
4,003,744
ROIC
39.15%
25.45%
ROCE
19.23%
14.50%
EV
Common stock shares outstanding
594,543
406,428
Price
25.79
20.40%
21.42
-33.48%
Market cap
15,333,263
76.13%
8,705,690
-33.48%
EV
11,823,341
6,921,296
EBITDA
1,929,177
1,213,936
EV/EBITDA
6.13
5.70
Interest
47,072
56,931
Interest/NOPBT
2.74%
5.60%